Tareq Abadl: Kell System and Anti-K Alloimmunization
Tareq Abadl, Medical Lab Specialist, shared a post on LinkedIn:
”Kell System and Anti-K Aloimunization
Why Is Anti-K So Important in Pregnancy?
What is anti-K
Anti-K is an IgG alloantibody directed against the Kell (K) antigen.
It can cross the placenta and cause HDFN.
How does alloimminization occur?
A K-negative mother may develop Anti-K after exposure to K-positive RBCs through:
- Previous pregnancy
- Blood transfusion
Why is anti-K dangerous?
Anti-K can cause fetal anemia through TWO mechanisms:
RBC Destruction
Destruction of K-positive fetal RBCs.
Erythropoiesis suppression
Anti-K can target erythroid precursor cells, reducing fetal RBC production.
Severe fetal anemia can occur.
Laboratory takeaway
When Anti-K is detected during pregnancy:
- Perform antibody identification
- Consider it clinically significant
- Provide K-negative compatible RBCs when transfusion is required
- Antibody titer alone should not be used to predict severity
Remember
Anti-K causes red blood cell destruction and suppression of red blood cell production.
A clinically significant antibody you should never overlook.”

Other posts featuring Tareq Abadl on Hemostasis Today.
-
Aug 29, 2026, 16:17The Future of Bleeding Disorder Research is Getting Bigger – Global Hemophilia Report
-
Aug 29, 2026, 16:03Marco De Giovanni: The Platelet – Serotonin Link Behind Severe COVID-19
-
Aug 29, 2026, 16:01FDA Approves Imaavy for wAIHA – Thalassaemia International Federation
-
Aug 29, 2026, 16:00Dianne E. van der Wal: Advancing Platelet Research at ISTH 2026 in Paris
-
Aug 29, 2026, 15:55Cory Dugan: Iron Deficiency and Anemia Across the Female Life
-
Aug 29, 2026, 15:53Melina Rodriguez: FDA Approves Imaavy as First Treatment for Warm AIHA
-
Aug 29, 2026, 15:50Karen T․: Seeking a Patient Liaison to Support the Bleeding Disorders Community
-
Aug 29, 2026, 15:49Ujjawal Agarwal: Alkem’s Fight Against Anemia in Rural Bihar
-
Aug 29, 2026, 15:44Christopher Cannon: Anticoagulation Shows Benefits Even in Low Risk Atrial Fibrillation Patients